X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement

NCT03608007 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
ROS1 Gene Rearrangement

Interventions

DRUG: X-396 Capsule

Sponsor

Betta Pharmaceuticals Co., Ltd.